You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Engetix and Takeda announce expanded collaboration for anti-fibrotic therapies

Engetix and Takeda will extend existing agreement to collaborate extensively in the development of therapeutics in IBD, including Crohn’s disease and ulcerative colitis.